Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Debu, Tripathy"'
Publikováno v:
Cancer Research. 80:P3-10
BACKGROUND: Eribulin mesylate, a non-taxane microtubule-dynamics inhibitor, is an effective chemotherapy drug for patients with metastatic breast cancer who have previously received at least two chemotherapeutic regimens. We are seeking to enhance th
Autor:
Evan N. Cohen, Alexandre Reuben, Naoto T. Ueno, James M. Reuben, Angela Alexander, Kumiko Kida, Charla A. Parker, Hui Gao, Bora Lim, S Tin, Debu Tripathy, Vicente Valero
Publikováno v:
Cancer Research. 80:P3-09
Background: Inflammatory breast cancer (IBC) and triple negative breast cancer (TNBC) are more aggressive than other breast cancer subtypes, and up until recently lacked therapy options that maintain acceptable quality of life. While chemotherapy is
Publikováno v:
Cancer Research. 79:P5-17
Background: Inflammatory breast cancer (IBC) is the most lethal and aggressive form of breast cancer and there are no approved targeted therapies specifically for IBC. Targeting the epidermal growth factor receptor (EGFR) pathway is a promising thera
Autor:
Debu Tripathy, Yun Gong, Juhee Song, Wendy A. Woodward, Naoto T. Ueno, Emilly S. Villodre, Richard A. Larson, Savitri Krishnamurthy, Xiaoding Hu, Bisrat G. Debeb, Xiaoping Wang, Omar M. Rahal
Publikováno v:
Communications Biology
Communications Biology, Vol 4, Iss 1, Pp 1-14 (2021)
Communications Biology, Vol 4, Iss 1, Pp 1-14 (2021)
Inflammatory breast cancer (IBC) is a clinically distinct and highly aggressive form of breast cancer with rapid onset and a strong propensity to metastasize. The molecular mechanisms underlying the aggressiveness and metastatic propensity of IBC are
Autor:
Ricardo H. Alvarez, Vicente Valero, Banu Arun, Gabriel N. Hortobagyi, Nuhad K. Ibrahim, Debu Tripathy, Diane Liu, Naoto T. Ueno, Marc Uemura, Wendy Woodward, Bora Lim, Kanwal Pratap Singh Raghav, John Thomas French, Kenneth R. Hess, Bisrat G. Debeb, Stacy L. Moulder
Publikováno v:
Cancer. 124:2299-2305
Background Inflammatory breast cancer (IBC) is associated with a poor prognosis and high risk of central nervous system (CNS) metastases. Methods We retrospectively reviewed stage III-IBC patients compared with noninflammatory invasive ductal carcino
Autor:
Gabriel N. Hortobagyi, Hiroko Masuda, Debu Tripathy, Takahiro Kogawa, Naoki Hayashi, Yuan Qi, Shuying Liu, Naoto T. Ueno
Publikováno v:
Oncotarget
// Hiroko Masuda 1, 2, 4 , Yuan Qi 3 , Shuying Liu 1 , Naoki Hayashi 1 , Takahiro Kogawa 1, 2 , Gabriel N. Hortobagyi 1 , Debu Tripathy 1 and Naoto T. Ueno 1, 2 1 Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Cente
Autor:
Adriana Priscila Trapé, Chandra Bartholomeusz, James M. Reuben, Hiroko Masuda, Dongwei Zhang, Takahiro Kogawa, Gabriel N. Hortobagyi, Yohei Funakoshi, Debu Tripathy, Bedrich L. Eckhardt, Naoto T. Ueno, Peiying Yang, Xiaoping Wang, Monica E. Reyes, Yun Gong, David Pirman, Wendy A. Woodward
Publikováno v:
Oncotarget
// Xiaoping Wang 1, 2, 3, * , Monica E. Reyes 1, 2, 3, * , Dongwei Zhang 1, 2, 3, * , Yohei Funakoshi 1, 2, 3 , Adriana P. Trape 1, 2, 3 , Yun Gong 1, 4 , Takahiro Kogawa 1, 2, 3 , Bedrich L. Eckhardt 1, 2, 3 , Hiroko Masuda 1, 2, 3 , David A. Pirman
Autor:
Kumiko Kida, Kenneth R. Hess, Sudpreeda Chainitikun, Savitri Krishnamurthy, Toshiaki Iwase, Anthony Lucci, Debu Tripathy, Gabriel N. Hortobagyi, Wendy A. Woodward, Carisa Le-Petross, Vicente Valero, Naoto T. Ueno, Maryanne E Sapon, Bora Lim
Publikováno v:
Cancer Research. 80:P5-06
Background: The American Joint Committee on Cancer (AJCC) recently updated its breast cancer staging system to incorporate biological factors, including estrogen and progesterone receptor (ER, PR), and HER2 status, in the new “prognostic stage” i
Autor:
Jeremy Mason, Naoto T. Ueno, Peter Kuhn, Debu Tripathy, Wendy A. Woodward, Takeo Fujii, Angela Chen, Paul K. Newton
Background Inflammatory breast cancer (IBC) is a rare yet aggressive variant of breast cancer with a high recurrence rate. We hypothesized that patterns of metastasis differ between IBC and non-IBC. We focused on the patterns of bone metastasis throu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce1ac359ffb8e30ee79fcecb187dbc63
https://europepmc.org/articles/PMC6795167/
https://europepmc.org/articles/PMC6795167/
Autor:
Kumiko Kida, Debu Tripathy, Gabriel N. Hortobagyi, Toshiaki Iwase, Vicente Valero, Savitri Krishnamurthy, Carisa Le-Petross, Naoto T. Ueno, Kenneth R. Hess, Anthony Lucci, Bora Lim, Sudpreeda Chainitikun, Wendy A. Woodward
Publikováno v:
Cancers
Cancers, Vol 12, Iss 3105, p 3105 (2020)
Volume 12
Issue 11
Cancers, Vol 12, Iss 3105, p 3105 (2020)
Volume 12
Issue 11
The AJCC updated its breast cancer staging system to incorporate biological factors in the &ldquo
prognostic stage&rdquo
We undertook this study to validate the prognostic and anatomic stages for inflammatory breast cancer (IBC). We establi
prognostic stage&rdquo
We undertook this study to validate the prognostic and anatomic stages for inflammatory breast cancer (IBC). We establi